Phadia US Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.0M | 88 | 31.4% |
| Food and Beverage | $794,749 | 36,437 | 24.5% |
| Honoraria | $745,839 | 422 | 23.0% |
| Consulting Fee | $546,777 | 145 | 16.9% |
| Travel and Lodging | $128,640 | 197 | 4.0% |
| Education | $2,531 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,225 | 2 | 0.1% |
| Charitable Contribution | $1,000 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CABAI 2104 Study Dynamics of SARS-CoV2 transmission and disease | $158,277 | 0 | 2 |
| Investigation of IgG4 and IgE Antibodies to the component proteins of Milk, Other Foods and inhalants associated with EoE | $125,880 | 0 | 2 |
| Development of IgG4 and IgE antibodies to food and food antigens during first 3 years of life in a random cohort | $122,376 | 0 | 2 |
| Diagnostic Performance of Boiled Milk IGE CAP in baked milk allergy in children | $97,218 | 0 | 2 |
| Investigating the Relevance of IgE to galactose (a-Gal) in coronary artery disease - CABAL 2015 CF | $61,459 | 0 | 1 |
| Improving Asthma Outcomes | $46,381 | 0 | 1 |
| Dietary Management of Adult and Childrens Eosinphilic Esophagitis: The Efficacy of dietary interventions | $45,641 | 0 | 5 |
| IDEA Investigating Duliumabs Effect on Asthma by Genotype- CABAL 1922 | $42,540 | 0 | 3 |
| Research Grant Agreement to determine the earliest risk factors for food allergy development. Evaluate sensitization to food allergens in children with FPIAP compared to healthy controls in the cohort | $40,087 | 0 | 3 |
| Dietary Management of Adult Eosinphilic Esophagitis: The Efficacy of dietary interventions | $39,287 | 0 | 8 |
| Controlling and Preventing Asthma Progression and Severity in kids with Omalizumab-Preventing Asthmas in High Risk Kids (PARK | $31,417 | 0 | 16 |
| Allergen Sensitization and Exposure Pilot | $30,640 | 0 | 2 |
| Use if Liklihood Ratios to Determine the Most Clinically and Cost Effective Predictor or Clinical Allergy | $25,000 | 0 | 1 |
| Duke Prestige Award Aeroallergen-sensitization and pulmunary function outcomes in children ith chronic respiratory disease | $25,000 | 0 | 1 |
| Advancing Understanding of the Diagnosis and Management of Childhood Allergy among Medicaid Enrolled Children | $19,890 | 0 | 1 |
| Inner City Asthma | $18,433 | 0 | 1 |
| Relevance of Der p23 to symptoms of asthma and rhinitis in an unselected birth cohort | $17,919 | 0 | 1 |
| Tryptase | $16,225 | 0 | 4 |
| Improving Technology-Assisted Recording of Asthma Control in Children | $11,693 | 0 | 10 |
| Family Member Screening for Celiac Disease | $11,519 | 0 | 2 |
| CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | $7,680 | 0 | 2 |
| Evaluation of the Phadia ImmunoCAP PR3, MPO and GBM | $6,912 | 0 | 1 |
| Testing the Efficacy of school based environmental intervention targeting pest allergens, mold and pollution | $4,874 | 0 | 2 |
| PARK CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | $4,510 | 0 | 3 |
| Diagnostic Performance of 2nd Generation tTG serological tests in different ethnic populations | $2,304 | 0 | 1 |
| CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | $2,100 | 0 | 8 |
| Multi Allergic Pilot Study | $592.00 | 0 | 1 |
| IDEA Investigating Duliumab's Effect on Asthma by Genotype- CABAL 1922 | $165.00 | 0 | 1 |
| Baked Egg Oral Immunology for Egg Allergic Children | $90.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dixie Reynolds, Arnp, ARNP | Pediatrics | Auburn, WA | $337.55 | $0 |
| Dr. Gustavo Morales, M.d, M.D | Pediatrics | Bronx, NY | $337.19 | $0 |
| Dr. Shahid Iqbal, M.d, M.D | Allergy & Immunology | Tampa, FL | $335.16 | $0 |
| Nikara Robinson, Arnp, ARNP | Family | Orlando, FL | $333.90 | $0 |
| Carina Buhay, Md, MD | Internal Medicine | San Bernardino, CA | $333.39 | $0 |
| David Fleischer, Md, MD | Allergy & Immunology | Aurora, CO | $329.78 | $0 |
| Sachi Ezaki, Pa-C, PA-C | Medical | Covina, CA | $328.08 | $0 |
| Deborah Scheuerell, N.p, N.P | Nurse Practitioner | Pomona, CA | $326.94 | $0 |
| Dr. Stella Delgado-Almenario, M.d, M.D | Pediatrics | Henderson, NV | $319.04 | $0 |
| Jennifer Vidal, D.o, D.O | Pediatrics | Harrison, NJ | $312.93 | $0 |
| Michael Gabriel, Md, MD | Pediatrics | Brooklyn, NY | $308.89 | $0 |
| Xiawei Zhong, D.o, D.O | Student in an Organized Health Care Education/Training Program | Orlando, FL | $305.64 | $0 |
| Dr. Hetu Parekh, Md, MD | Allergy & Immunology | Austin, TX | $304.60 | $0 |
| Lora Torres, Md, MD | Pediatrics | Houston, TX | $302.71 | $0 |
| Simone Majetich, D.o, D.O | Student in an Organized Health Care Education/Training Program | Richmond Heights, OH | $301.00 | $0 |
| Dr. Blake Scheer, M.d, M.D | Allergy & Immunology | Little Rock, AR | $296.92 | $0 |
| Dr. Hiran Wijesinghe, Md, MD | Emergency Medicine | North Las Vegas, NV | $296.19 | $0 |
| Lee Hilborne, Md, MD | Anatomic Pathology & Clinical Pathology | Los Angeles, CA | $293.92 | $0 |
| Sherley David Gratia, Pnp-Bc, PNP-BC | Pediatrics | Boynton Beach, FL | $291.53 | $0 |
| Minal Patel | Pediatrics | Clovis, CA | $290.46 | $0 |
| Elizabeth Grace, Np-C, NP-C | Family | College Station, TX | $284.92 | $0 |
| Britni Lehde | Pediatrics | Bryan, TX | $284.92 | $0 |
| Mrs. Corinne Maxwell, Pa-C, PA-C | Pediatrics | Upland, CA | $281.20 | $0 |
| Roselynn Cuenca, M.d., M.p.h, M.D., M.P.H | Pediatrics | Puyallup, WA | $280.02 | $0 |
| Dr. Rebin Kader, D.o, D.O | Allergy | Washington, DC | $279.15 | $0 |
Top Products
- ImmunoCAP $3.0M
- Phadia 250 $96,837
Associated Products (4)
- ImmunoCAP $3.0M
- Phadia 250 $96,837
- ELIA $61,440
- EliA $60,836
Payment Categories
- Food & Beverage $794,749
- Consulting $546,777
- Travel & Lodging $128,640
- Research $1.0M
About Phadia US Inc.
Phadia US Inc. has made $3.2M in payments to 24,019 healthcare providers, recorded across 37,293 transactions in the CMS Open Payments database. In 2024, the company paid $339,519. The top product by payment volume is ImmunoCAP ($3.0M).
Payments were distributed across 201 medical specialties. The top specialty by payment amount is Allergy & Immunology ($534,776 to 704 doctors).
Payment categories include: Food & Beverage ($794,749), Consulting ($546,777), Research ($1.0M), Travel & Lodging ($128,640).
Phadia US Inc. is associated with 4 products in the CMS Open Payments database, including ImmunoCAP, Phadia 250, and ELIA.